165 related articles for article (PubMed ID: 11112459)
1. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells.
Qin XP; Ye F; Hu CP; Liao DF; Deng HW; Li YJ
Eur J Pharmacol; 2004 Mar; 488(1-3):45-9. PubMed ID: 15044034
[TBL] [Abstract][Full Text] [Related]
4. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan.
McCaffrey TA; Falcone DJ; Vicente D; Du B; Consigli S; Borth W
J Cell Physiol; 1994 Apr; 159(1):51-9. PubMed ID: 7511146
[TBL] [Abstract][Full Text] [Related]
5. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
[TBL] [Abstract][Full Text] [Related]
6. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
7. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
Roztocil E; Nicholl SM; Galaria II; Davies MG
Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
[TBL] [Abstract][Full Text] [Related]
8. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
Geraldes P; Sirois MG; Tanguay JF
Circ Res; 2003 Sep; 93(5):399-405. PubMed ID: 12893737
[TBL] [Abstract][Full Text] [Related]
9. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
[TBL] [Abstract][Full Text] [Related]
11. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
12. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
13. Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells.
Ghiselli G; Chen J; Kaou M; Hallak H; Rubin R
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1808-13. PubMed ID: 12907464
[TBL] [Abstract][Full Text] [Related]
14. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
15. Effects of heparin on growth factor-induced mitogenic and proliferative responses of rat pulmonary artery smooth muscle cells.
Wang HL; Kilfeather SA; Martin GR; Page CP
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):397-400. PubMed ID: 10322925
[TBL] [Abstract][Full Text] [Related]
16. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin II on human vascular smooth muscle cell growth.
Mii S; Ware JA; Mallette SA; Kent KC
J Surg Res; 1994 Jul; 57(1):174-8. PubMed ID: 8041134
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
[TBL] [Abstract][Full Text] [Related]
19. Cellular effects of factor Xa on vascular smooth muscle cells--inhibition by heparins?
Bretschneider E; Schrör K
Semin Thromb Hemost; 2001 Oct; 27(5):489-93. PubMed ID: 11668418
[TBL] [Abstract][Full Text] [Related]
20. Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism.
Vischer P; Buddecke E
Eur J Cell Biol; 1991 Dec; 56(2):407-14. PubMed ID: 1802722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
